Johnson and Johnson

KEI Comments to CMS Regarding Imbruvica (INN:Ibrutinib) R&D (regarding Medicare pricing negotiations)

Posted on by Claire Cassedy

On October 2, 2023, Knowledge Ecology International submitted written comments to the Centers for Medicare & Medicaid Services (CMS) in conjunction with the Medicare Price Negotiation public consultation process. CMS is hosting a series of patient-focused listening sessions this fall,… Continue Reading →

COVID-19 Contracts

United States of America Below are links to copies of the contracts entered into by the US government for technologies to combat the COVID-19 pandemic. KEI is updating this page as we gain access to more contracts, and less redacted… Continue Reading →

KEI Submission to WHO Essential Medicines List – Enzalutamide / Abiraterone Acetate

Posted on by Claire Cassedy

The WHO Essential Medicines List is a major WHO tool used to expand access to medicines.  In 2017, the WHO issued the 20th Essential Medicines List (EML) which was the 40th anniversary of the list.  The WHO is currently in… Continue Reading →